AzTrials
AzTrials

Critical IllnessFASTERNCT03513861

Family Assisted Severe Febrile Illness Therapy for Critically-ill Kenyan Children

A study testing FASTER Assessment tool in people with Critical Illness and Febrile Illness, run by Seattle Children's Hospital at 1 site in Kenya.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this pilot study is to improve inpatient monitoring of severely-ill children admitted to the hospital in low resource settings at Kenyatta National Hospital in Nairobi, Kenya. Read more about this study

Who is it for?
Ages 2 months to 12 years
Conditions the study is for
Critical Illness, Febrile Illness
What is being tested?
FASTER Assessment tool
Could I receive a placebo?
No, everyone receives an active treatment
How many people
182 participants
Where
1 siteKenya
Study dates
8 May 2017to 30 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 months to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Admitted to Kenyatta National Hospital with severe febrile illness which includes presumed malaria, sepsis or septic shock, pneumonia, meningitis or encephalitis
  • Available adult caregiver
  • Enrollment within the first 8 hours of admission to the pediatric ward (modified to 16 hrs later)

Who cannot join

  • Primary cause of admission is major bleed or hemorrhagic shock, severe trauma or burn, major surgery, known congenital heart disease
  • Previous study enrollment
  • No available adult caregiver
  • Caregiver unable to give informed consent
  • Caregiver not proficient in English or Swahili

Trial locations and contacts

1 site in 1 country.

Kenya1 site
  • Kenyatta National Hospital

    Nairobi

Other trials in Kenya

About this study

Official title: Family Assisted Severe Febrile Illness Therapy (FASTER) for Critically-ill Kenyan Children

The purpose of this pilot study is to improve inpatient monitoring of severely-ill children admitted to the hospital in low resource settings at Kenyatta National Hospital in Nairobi, Kenya. Given the high ratio of patients to medical staff in these settings, the lack of reliable patient monitoring tools, and the high rate of early inpatient mortality, we will prospectively train parents as monitoring aids of their hospitalized children. Early recognition and intervention in critical illness is important to avoid (further) organ failure. Parents will be taught how to assess their child's mental status, work of breathing and capillary refill time which will inform a 3-point severity of illness scale. The severity of illness will be conveyed by the parents to the medical staff via color-coded flag system. The goal is to increase the healthcare provider patient reassessment rate according to patients' level of severity to assist in early recognition and treatment of patients' deterioration.

Being tested
FASTER Assessment tool
Keywords
Low and Middle Income Countries, Limited resource settings, Early warning signs
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FASTER Assessment toolOther

    The FASTER assessment tool consists of monitoring mental status, respiratory distress and capillary refill time by parents of children admitted to the hospital with febrile illness. Parents in the intervention group are asked to monitor their child hourly with the FASTER tool and signal severity of illness to the healthcare team via color coded flag system. Number of healthcare provider - patient reassessments will be compared in intervention and control group.

Study groups in NCT03513861
Study groupRoleWhat they receive
Aim 1: Parental FASTER tool trainingExperimentalThe goal is to see whether the child's parent/ guardian can be trained in overall severity of illness assessment using the FASTER Tool, to match the performance of a professional.
Receives: Other: FASTER Assessment tool
Aim 2: Intervention groupActive comparatorThe intervention group parents will be taught the FASTER assessment tool. Intervention group parents will each be asked to monitor their own hospitalized child hourly using the FASTER assessment tool, and put up color-coded flags indicating severity of illness to the healthcare team. Parents will record the frequency of healthcare provider assessments of their child over the 24 hour intervention period.
Receives: Other: FASTER Assessment tool
Aim 2: Control GroupNo interventionThe control group parents will not be taught the FASTER assessment tool. Hence they will not be involved in monitoring their child, nor signaling severity of their child's illness per color-coded flag system. Control group parents will record the frequency of healthcare provider assessments of their child over the 24 hrs enrollment period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Healthcare provider assessment rate of patient

    Number of assessments of study patient by nurses or doctors within the 24 hrs intervention period

    Measured: First 24 hrs after enrollment

Secondary outcomes (11)
  1. Association of number of healthcare provider assessments within 24 hours with survival to discharge.

    Number of healthcare provider assessments will be associated with survival to discharge.

    Measured: First 24 hrs after enrollment

  2. Association of number of healthcare provider assessments within 24 hours with hospital length of stay.

    Number of healthcare provider assessments will be associated with hospital length of stay.

    Measured: First 24 hrs after enrollment

  3. Association of number of healthcare provider assessments within 24 hours with need of patient transfer to the pediatric ICU (PICU).

    Number of healthcare provider assessments will be associated with need for transfer to the PICU.

    Measured: First 24 hrs after enrollment

  4. Association of number of healthcare provider assessments within 24 hours with need of patient transfer from the acute room to the regular pediatric ward.

    Number of healthcare provider assessments will be associated with need for patient transfer from the acute room that provides closer monitoring to regular pediatric ward.

    Measured: First 24 hrs after enrollment

  5. Association of number of healthcare provider assessments within 24 hours with number of clinical procedures and interventions performed.

    Number of healthcare provider assessments will be associated with the number of clinical procedures performed on patients. Invasive clinical procedures include, but are not limited to lumbar puncture, thoracentesis, abscess drainage). Interventions included are blood transfusion given; antibiotics or antimalarials given; fluid bolus given.

    Measured: First 24 hrs after enrollment

  6. Association of number of healthcare provider assessments within 24 hours with the change in Pediatric Early Warning Score (PEWS) between time of enrollment and 24 hour time point

    Number of healthcare provider assessments will be associated with the change in patients' PEWS score between time of enrollment and 24 hrs status post enrollment. The bedside PEWS is measured by 6 components, including heart rate, systolic blood pressure, capillary refill time, respiratory rate, oxygen saturation, respiratory effort and oxygen therapy. The score ranges between zero to 24 point, with 24 point representing the highest severity level.

    Measured: First 24 hrs after enrollment

  7. Initial PEWS and change in PEWS from enrollment to 24 hrs in intervention vs control group will be correlated with the need for patients requiring transfer to PICU.

    The goal of this outcome is to see if patients with equivalent levels of illness severity in both intervention and control group, exhibit differences in need for transfer to the intensive care unit.

    Measured: First 24 hrs after enrollment

  8. Initial PEWS and change in PEWS score over 24 hrs in intervention vs control group will be correlated with mortality.

    The goal of this outcome is to see if patients with equivalent levels of illness severity in both intervention and control group, exhibit differences in mortality.

    Measured: First 24 hrs after enrollment

  9. Proportion of concordant FASTER assessments between parents and research team for Aim 1 patients and Aim 2 intervention group patients

    The goal of this outcome is to assess the accuracy of the parental FASTER assessments compared to the gold standard which is the research team's FASTER assessment.

    Measured: First 24 hrs after enrollment

  10. Correlation of PEWS score with Research team's FASTER tool assessments for Aim 1 patients and in both control and intervention group for Aim 2 patients

    The bedside PEWS is measured by 6 components, including heart rate, systolic blood pressure, capillary refill time, respiratory rate, oxygen saturation, respiratory effort and oxygen therapy. The score ranges between zero to 24 point, with 24 point representing the highest severity level.

    Measured: First 24 hrs after enrollment

  11. Association of parental level of education with correct parental severity of illness level assessment compared to research team assessments in intervention group patients.

    This outcome will assess if level of parental education has an impact on the correct use of the FASTER tool. There are up to 24 separate parental FASTER assessments and 4 research team assessments per patient. Parental and research team assessment have to occur within 1 hr of one another to qualify for comparison.

    Measured: First 24 hrs after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2018
  2. Study start8 May 2017
  3. Primary completion30 Nov 2017
  4. Study completion30 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
182 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03513861
Sponsor's protocol ID
24080017
Acronym
FASTER
Status last verified
Apr 2018
First submitted
6 Jan 2018
Last updated
2 May 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • von Saint Andre-von Arnim AO, Kumar RK, Clark JD, Wilfond BS, Nguyen QP, Mutonga DM, Zimmerman JJ, Oron AP, Walson JL. Family-Assisted Severity of Illness Monitoring for Hospitalized Children in Low-Resource Settings-A Two-Arm Interventional Feasibility Study. Front Pediatr. 2022 May 23;10:804346. doi: 10.3389/fped.2022.804346. eCollection 2022.

    PubMed 35676898
  • von Saint Andre-von Arnim AO, Kumar RK, Oron AP, Nguyen QP, Mutonga DM, Zimmerman J, Walson JL. Feasibility of Family-Assisted Severity of Illness Monitoring for Hospitalized Children in Low-Income Settings. Pediatr Crit Care Med. 2021 Feb 1;22(2):e115-e124. doi: 10.1097/PCC.0000000000002582.

    PubMed 33031354

Questions about this trial

What is this clinical trial studying?

A study testing FASTER Assessment tool in people with Critical Illness and Febrile Illness, run by Seattle Children's Hospital at 1 site in Kenya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Healthcare provider assessment rate of patient (time frame: First 24 hrs after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03513861, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in